NOV News

Latest NOV News

• Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
  TipRanks Auto-Generated Newsdesk · Oct 13, 2026
• Barclays Keeps Their Hold Rating on Novartis AG (NOVN)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
• Restart Life Advances Licensed Health Brands Toward Commercial Launch
  TipRanks Canadian Auto-Generated Newsdesk · Oct 8, 2026
• Deutsche Bank Keeps Their Sell Rating on Novo Nordisk (0QIU)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
• Analysts Conflicted on These Technology Names: AST SpaceMobile (ASTS) and Novanta (NOVT)
  TipRanks Newsroom · Oct 5, 2026
• J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 5, 2026
• Novina PozyczkiHipoteczne.eu Expands Share Buyback to 1.22% of Capital
  TipRanks Poland Auto-Generated Newsdesk · Oct 2, 2026
• Goldman Sachs Remains a Sell on Novartis AG (NOVN)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
• RBC Capital Remains a Hold on Novartis AG (NOVN)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
• Schroders Capital Global Innovation Trust Confirms Voting Rights and Share Capital
  TipRanks UK Auto-Generated Newsdesk · Sep 30, 2026
• Wall Street Analysts Are Bullish on Top Healthcare Picks
  TipRanks Newsroom · Sep 30, 2026
• Deutsche Bank Remains a Sell on Novo Nordisk (0QIU)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 29, 2026
• Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 25, 2026
• Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
  Newswire TipRanks · Sep 25, 2026
• Novina PozyczkiHipoteczne.eu Expands Share Buyback on NewConnect
  TipRanks Poland Auto-Generated Newsdesk · Sep 24, 2026
• Restart Life Sciences launches HC Protein+ line and accelerates AI-driven e-commerce push
  TipRanks Canadian Auto-Generated Newsdesk · Sep 23, 2026
• HSBC Remains a Buy on Novartis AG (NOVN)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 23, 2026
• Novo Nordisk (NVO) Receives a Hold from Jefferies
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 22, 2026
• Deutsche Bank Sticks to Its Sell Rating for Novo Nordisk (0QIU)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 22, 2026
• UBS Sticks to Its Hold Rating for Novo Nordisk (0QIU)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 22, 2026